Chimeric antigen receptor T-cell therapy's role in antiphospholipid syndrome: a case report.

Schmelz, Jacob L; Navsaria, Lucy; Goswamy, Rohit; Chuang, Hubert H; Miranda, Roberto N; Lee, Hun Ju

Schmelz, Jacob L; Navsaria, Lucy; Goswamy, Rohit; Chuang, Hubert H; Miranda, Roberto N; Lee, Hun Ju.

Affiliation

Schmelz JL; McGovern Medical School at UTHealth, Houston, TX, USA.
Navsaria L; Department of Lymphoma & Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Goswamy R; Department of Lymphoma & Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Chuang HH; Department of Nuclear Medicine, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Miranda RN; Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lee HJ; Department of Lymphoma & Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Br J Haematol ; 188(3): e5-e8, 2020 02.

Article in En | MEDLINE | ID: mdl-31721157

Subject(s)
Key words

antiphospholipid syndrome; autoimmune diseases; cell- and tissue-based therapy; diffuse large B cell; immunotherapy; lymphoma

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Facial Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Immunotherapy, Adoptive / Lymphoma, Large B-Cell, Diffuse / Antiphospholipid Syndrome / Rituximab Limits: Aged / Female / Humans Language: En Journal: Br J Haematol Year: 2020 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google